Medicines of botanical origin for the treatment of addictions

NFL Biosciences develops botanical medicines for the treatment of addictions, with the goal of eventually partnering them with pharmaceutical companies

CESTO II study results

bt_bb_section_bottom_section_coverage_image

Our expertise

Focus on the 3 most common addictive substances, which are frequently present at the same time

https://www.nflbiosciences.com/wp-content/uploads/2023/05/pawel-czerwinski-7USMFYqt1NI-unsplash-1.jpg

Tobacco

https://www.nflbiosciences.com/wp-content/uploads/2023/05/julia-kicova-CXZUyCQjxAk-unsplash-1.jpg

Alcohol

https://www.nflbiosciences.com/wp-content/uploads/2023/05/paul-einerhand-39F7_IfT-r0-unsplash-1.jpg

Cannabis

Revolutionizing withdrawal treatments

NFL-101: An innovative drug candidate for smoking cessation derived from a nicotine-free tobacco leaf protein extract

NFL-101

NFL 301: A drug candidate to combat excessive alcohol consumption from a traditional Chinese medicine plant

NFL-301

NFL BIOSCIENCES KEY FIGURES

2021

Initial Public Offering

8 m€

raised on Euronext Growth

clinical studies on NFL-101

An outsourced scientific research company with low operating costs

PRECLINICAL AND CLINICAL STUDIES

HIGH ENVIRONMENTAL IMPACT APPROACH

SEVERAL SCIENTIFIC AWARDS

GLOBAL SCIENTIFIC EXPERTISE IN BOTANICAL MEDICINES

4 PATENT FAMILIES

MANUFACTURING IN FRANCE AND RESPECT FOR BPF

PIPELINE